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REVIEW

Review Article on Advanced Polymers Use in
Gastroretentive Drug Delivery Systems
Firas A. Rahi
Department of Pharmacy, Al-Nisour University College, Baghdad, Iraq

Abstract
Conventional dosage forms could not manage release of active substances resulting in reduced bioavailability and
side reactions. Being retained in a certain site in the gastrointestinal tract (GIT) could achieve further bioavailability
particularly regarding drugs having low gastric absorption and low solubilization or less stability at elevated pH.
Therefore, Gastroretentive drug delivery systems (GDDS) are unique approaches with gastric retention and controlling
the release rate for maximizing the efﬁcacy. The polymers broadly applied in GDDS are mainly of two sorts, natural and
synthetic, according to their nature. Synthetic polymers such as Hydroxypropylmethyl cellulose (HPMC), Eudragit and
Ethylcellulose while natural polymers such as natural gums, sodium alginate and Chitosan.
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1. Introduction

O

ral delivery is broadly applied route to medicines comparing to other routes. Several variables may affect absorption of drug, such as
unwanted physical and chemical characteristics, site
of absorption, gastric emptying, and GIT transit
time. The primary drug absorption sites are stomach
and upper small intestine. It is essential to prolong
the time of residence at or prior to the location of
absorption for optimization of bioavailability,
reduction of doses, and achieving patient compliance [1]. GDDS are novel methods invented to
overcome obstacles by keeping away from the ﬁrst
pass to maximize bioavailability. The continuous
release of the drug conserves the therapeutic level
constant. Drugs having shorter half-lives can
perform relatively higher therapeutic response
when formulated in GDDS. The prevalent GDDS
systems such as the ﬂoating and pulsating drug
delivery system (FDDS/PDDS) that enhance efﬁcacy
by extending the GRT (gastric retention time) either
effervescent or non-effervescent [2e4]. Furthermore, GDDS can achieve the controlled delivery of
drugs by keeping steady release for a prolonged
time at the wanted rate and to the wanted location of

absorption until the drug is totally free from the pills
[5e7]. Many polymers are used in GDDS that can be
categorized into two types according to their origin.
1.1. Synthetic polymers
The synthetic polymers perform a chief role in the
pharmaceuticals employing as binders, ﬁlm coating
agent, etc. They may be either 100% synthetic or
manufactured from a natural one. For instance,
HPMC, ethyl cellulose and Eudragit. They have
some drawbacks like high cost, pollution, low
biocompatibility and sensitivity [8].
1.1.1. Hydroxypropyl methyl cellulose (HPMC,
hypromellose)
HPMC is white, water soluble powder. It is semi
synthetic, inert, viscoelastic polymer, applied in
pharmaceuticals as an excipient and controlled-delivery component. They solubilize in cold water,
composing a viscous colloid but it is characterized by
insolubility in hot water, and ethyl alcohol (95%).
Nevertheless, certain sorts may swell in ethyl alcohol
[9]. They are used as bioadhesive, ﬁlm composing
and sustained release materials. Grades having high
viscosity are utilized to sustain the release of active
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materials at percent 10e80% w/w. The HPMC is
utilized in oral syrups at 2e5% as suspending and/or
thickening substances. Percent from 2 to 20% w/w
depending on the viscosity is utilized in ﬁlm coating
tablets such as pharmacoat [10].
Rahamathulla et al. prepared losartan potassium
effervescent ﬂoating GDDS employing HPMC
15,000 and karaya gum. Losartan potassium is less
soluble at high pH resulting in reduced bioavailability. Therefore, GDDS were invented to extend
GRT and enhancing its bioavailability. The tablets
exhibited acceptable ﬂoating for 24 h, and extended
release for 24 h. The optimized formula F3 containing HPMC released 100% drug in 24 h. Moreover, its ﬂoating was continuous in the stomach of
rabbit as the GRT exceeded 12 h. Its bioavailability
was maximized comparing to losartan potassium
oral solution [11].
1.1.2. Eudragit (polymeric methacrylates)
Eudragits are marketed as dry powders and
emulsions. Acetone and isopropanol)60:40) mixed
solution is employed to dissolve Eudragit. 95%
acetone and alcohol are used to dissolve Eudragit S
100 that is exist as a powder utilizing for enteric
coating to withstand eroding in stomach and allow
release in enteric ﬂuid of pH 7. They can solubilize
immediately in neutral to weak basic and, can form
membrane sheaths that are tolerant to the juice of
stomach and erodible in the ﬂuid of intestine [12].
Eudragits are mainly utilized in oral capsules and
tablets as coating. According to the type of polymer
used, ﬁlms melting differs. Eudragit S 100 dissolves
in acetone and ethyl alcohol. Eudragit species are
utilized to enteric coating due to their tolerance to
gastric ﬂuid. Eudragit RL, RS, NE 30D, NE 40D and
NM30D could create water insoluble ﬁlm coating in
extended release dosage forms. Eudragit RL produces permeable ﬁlms more than those of Eudragit
RS, mixing them allow variable permeability. Larger
amounts (5e20%) of the dried Eudragit are employed
to manage the dissolution from the tablets. In percentage range (10e50%), dried polymers are
employed in direct compression. Eudragits were also
employed for transdermal route and new gel to use
rectally. Eudragit E are utilized in microparticles,
nanoparticles, ophthalmic liquids and GDDS [12].
Many studies included using of Eudragit in GDDS
such as Gupta et al. introduced famotidine GDDS to
target stomach to treat ulcer using Eudragit S100.
Results indicating good ﬂoating and SEM studies
conﬁrmed ﬂoating cavity and porous surface of
microsphere [13]. Also, Tort et al. produced pramipexole nanoﬁbers GDDS made from Eudragit RL
and RS. The nanoﬁber formulae showed ﬂoating lag

time lower than 1 s and provided sustained release
[14].
1.1.3. Ethyl cellulose
Ethocel (Ethylcellulose) is employed in pharmaceuticals for numerous purposes like masking the
bitter taste of some drugs, moisture protection, stabilizing, extended-release multi-particle coating,
precision packaging, and prolonged release. Ethocel
is water insoluble. And it does not solubilize in the
acidity of the stomach; however, it swells in the
stomach and becoming permeable to water, allowing the extended release [15].
Ethocel is rarely applied in wet extrusion due to
having great elasticity; however, it is applied successfully in corporation with some plasticizer. The
ﬁne and coarse Ethocel are utilized in extrusion and
water may be employed in wet granulation when
using ﬁne one. A few kinds of Ethocel has been
permitted to be used in extended-release solid
dosage and GDDS. There are several types of ethylcellulose that are dissimilar in the viscosity and
length of the chains [16].
El-masry MS et al. prepared GDDS of cefditoren
pivoxil to enhance its solubility and increase its
bioavailability. Cefditoren solid dispersions (SDs)
were formulated by polyvinylpyrrolidone (PVP) and
Poloxamer 188. The formulated SDs improved cefditoren release when comparing with pure substance. SDs PVP were chosen to compose GDDS.
Polymers including HPMC K15M or ethyl acetate
were applied using gas-generating substances (citric
acid and sodium bicarbonate). The optimized formula exhibits excellent sustained release proﬁle
[17].
1.2. Natural polymers
They are originated from plants. Moreover, they
are hydrophilic carbohydrate polymers. They are
insoluble in organic solvents and were discussed
below:
1.2.1. Chitosan
It is natural polymer manufactured from chitin. It
is characterized by desirable biological characteristics like non toxicity, biodegradability, and biocompatibility. Due to having bioadhesive ability, it is
appropriate for site delivery and FDDS. In neutral
and acidic circumstances, it shows buoyancy and
extends release. Enlarging thickness of chitosan ﬁlm
reduce release rate. As the ﬁlm of chitosan thickened more, the dissolution is reduced that decreases
inﬂuence of GIT transit time. Hollow microparticles
ﬂoat for 12 h in stomach. Kulkarni et al., prepared
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glipizide GDDS using chitosan/xanthan gum mixtures to obtain dense particles. The study results
revealed that the chitosan/xanthan gum ratio
affected the mucoadhesive characteristics [18,19].
Kaewkroek K et al. developed starch e chitosan ﬁlm
to deliver ginger GDDS in controlling release of 90%
of 6-gingerol after 8 h [20].
1.2.2. Natural gums
Xanthan gum is a polysaccharide obtained from
fermentation of carbohydrates. It dissolves in acidic
and alkaline solutions. It can either enlarge or
reduce the drug release rate. It is soluble in water. It
has elevated viscosity at low percent and this is a
great advantage for drug release. Moreover, it has
been proven that some tablets containing xanthan
gum in corporation with citric acid were able to ﬂoat
for 24 h. Gellan gum is a polysaccharide after
fermentation of spingomonas elodea. It is characterized by astonishing release, high strength, stability,
ﬂexibility, high clarity, good ﬁlm composer and
reversible gelling. On addition of positively charged
ions, it undergoes gelling [21].
Guar gum is polysaccharide. It is characterized by
solubility in water and insolubility in organic solvents. Guar gum undergoes hydration and swelling
in cold water composing viscous colloid. Its ability
of gelling delays the release and act as an ideal
carrier for GDDS. It is applied as a softener and as a
polymer in a FDDS. Guar gum is advantageous
GDDS due to the swelling of the polymer. Other
types of gum are used such as okra gum, karaya
gum, fenugreek gum and mimosa gum.
A lot of studies investigated using natural gums.
For instance, Sabale et al. developed famotidine
gastroretentive tablets applying guar gum to invent
controlled release tablets by increasing GRT of
famotidine. Six formulae exhibit good physicochemical properties. GDDS containing natural
polymer revealed extended drug release. The optimized formula had good ﬂoating and the release
was controlled [22]. Moreover, Lad G.C et al.
designed metformin hydrochloride ﬂoating tablets
to investigate natural polymers effect on dissolution
including okra gum and fenugreek gum. Addition of
sodium bicarbonate to generate gases that releases
carbon dioxide in to preserve the buoyancy. Metformin hydrochloride is not totally absorbed from
GI tract, its absorption window referred to the upper
GI tract, having short half-life (2 h) and bad
bioavailability (50e60%). Side effects of metformin
hydrochloride happened in 30% patients, particularly in ﬁrst weeks. To increase patient compliance,
the sustained release (SR) ﬂoating trials achieved
good bioavailability and efﬁcacy [23].
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1.2.3. Sodium alginate
Sodium alginate is practically insoluble in ethanol
(95%), and acidic solutions. It solubilizes in aqua,
turns into a gel, therefore, it can to be applied in
GDDS. It has various marketed sorts. Viscosity differs affected by some factors like percent and the
existence of some ions. Moreover, it reduces at an
elevated pH [24].
Some researchers investigated role of sodium
alginate in GDDS. For example, Srinivas L invented
and assessed Lafutidine GDDS formulae applying
BoxeBehnken design. The buoyancy lag time of
formulae was from 14 to 25 s, the time of gelling
exceeded 12 h, and the release was 86.86e99.34% in
12 h. The optimized formula (sodium alginate,
HPMC K4M, xanthan gum) exhibited the best
characteristics [25]. Furthermore, Palanivelu M et al.
formulated ranitidine hydrochloride GDDS microsphere using sodium alginate, Carbomer and Chitosan. The microspheres were evaluated including
the percentage yield ranged from 58% to 90% and
the in-vitro buoyancy of the microspheres ranged
from 67% to 81% [26].

2. Conclusion
The inability to maintain some active substances
in stomach or upper small intestine may lead to
insufﬁcient bioavailability to many active materials
that are less soluble in or degraded in higher pH of
intestinal ﬂuid or drugs with difﬁculty to be absorbed. Therefore, GDDS are essential approach for
prolonging keeping of drugs in site, performing
controlled release and enhancing bioavailability.
Polymeric substances perform a crucial role in
keeping of the dosage form of many active substances in stomach either by ﬂoating or by any other
mechanisms. Polymers used types and their role
were discussed in details.
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